Biodexa Pharmaceuticals PLC (BDRX)

1.90 -0.09 (-4.52%) USD  |  NASDAQ  |  Mar 14, 16:00
1.85 -0.05 (-2.63%) After-Hours: 20:00
More

Biodexa Pharmaceuticals Enterprise Value: -4.640M for March 14, 2025

Enterprise Value Chart

View Enterprise Value for BDRX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Enterprise Value Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Enterprise Value Definition

View Enterprise Value Definition
Start Trial

EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.

Read full definition.

Enterprise Value Range, Past 5 Years

View Enterprise Value Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Enterprise Value Benchmarks

View Enterprise Value Benchmarks
Start Trial
Verona Pharma PLC 4.937B
NuCana PLC -12.20M
TC BioPharm (Holdings) PLC -0.3828M
Autolus Therapeutics PLC -159.42M
Bicycle Therapeutics PLC -211.72M

Enterprise Value Related Metrics

Earnings Yield -3.93K%
Normalized Earnings Yield -14262.20